Tamás Forster

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Guidelines on the diagnosis and management of acute pulmonary embolism

Adam Torbicki, Arnaud Perrier, Stavros Konstantinides et al. · European Heart Journal · 2008 · 2.8K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Paul M. Ridker, Jean MacFadyen, Peter Libby et al. · The Lancet · 2017 · 886 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +8

Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography

Albert J. McNeill, El-Said M. El-Said, Alessandro Salustri et al. · The American Journal of Cardiology · 1992 · 404 citations

Medicine, Cardiology, Pharmacology +16